Venetoclax combined with R‐ICE (VICER) for second line treatment of diffuse large B cell lymphoma refractory or relapsed after initial chemoimmunotherapy
Gespeichert in:
| Veröffentlicht in: | Hematological oncology 2023-06, Vol.41 (S2), p.436-437 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 437 |
|---|---|
| container_issue | S2 |
| container_start_page | 436 |
| container_title | Hematological oncology |
| container_volume | 41 |
| creator | Caimi, P. F. Cashen, A. Gallogly, M. Winter, A. Boughan, K. Ghobadi, A. Jagadeesh, D. Cooper, B. Mehta‐Shah, N. Dean, R. Metheny, L. Pohlman, B. Bartlett, N. L. Lima, M. Kahl, B. S. Hill, B. T. |
| description | |
| doi_str_mv | 10.1002/hon.3164_321 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_3089979293</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3089979293</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1494-2e2af5dfb4444e854cd2d9a1edd97d67860aec93572f42d6f6554bb10ce6cb433</originalsourceid><addsrcrecordid>eNp9kN9qFTEQxhdR8Nh65wMMeKPgtkn2by71UNtCaaFob0M2mbgp2c2a5NDuXR_Be9-uT2IOR2-dixmG-fF9zFcU7yg5oYSw09HPJxVta1Ex-qLYUMJ5SUnLXxYbwrq-JKxir4s3Md4Tkm-k3xS_73DG5JWTj6D8NNgZNTzYNMLt89Ovy-0ZfLjL_fYjGB8govKzBpcpSAFlmnBO4A1oa8wuIjgZfiB8AYXOgVunZfSThIAmSJV8WCGLBHRyidlGmoQB7GyTlQ7UiJO307SbfRoxyGU9Ll4Z6SK-_TuPiu9fz75tL8qrm_PL7eerUtGa1yVDJk2jzVDnwr6plWaaS4pa8063Xd8SiYpXTcdMzXRr2qaph4ESha0a6qo6Kt4fdJfgf-4wJnHvd2HOlqIiPecdZ3xPfTpQKvgY80tiCXaSYRWUiH38Iscv_sWf8eaAP1iH639ZcXFzvR_7vfoD1iKMPQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3089979293</pqid></control><display><type>article</type><title>Venetoclax combined with R‐ICE (VICER) for second line treatment of diffuse large B cell lymphoma refractory or relapsed after initial chemoimmunotherapy</title><source>Wiley Online Library</source><creator>Caimi, P. F. ; Cashen, A. ; Gallogly, M. ; Winter, A. ; Boughan, K. ; Ghobadi, A. ; Jagadeesh, D. ; Cooper, B. ; Mehta‐Shah, N. ; Dean, R. ; Metheny, L. ; Pohlman, B. ; Bartlett, N. L. ; Lima, M. ; Kahl, B. S. ; Hill, B. T.</creator><creatorcontrib>Caimi, P. F. ; Cashen, A. ; Gallogly, M. ; Winter, A. ; Boughan, K. ; Ghobadi, A. ; Jagadeesh, D. ; Cooper, B. ; Mehta‐Shah, N. ; Dean, R. ; Metheny, L. ; Pohlman, B. ; Bartlett, N. L. ; Lima, M. ; Kahl, B. S. ; Hill, B. T.</creatorcontrib><identifier>ISSN: 0278-0232</identifier><identifier>EISSN: 1099-1069</identifier><identifier>DOI: 10.1002/hon.3164_321</identifier><language>eng</language><publisher>Chichester: Wiley Subscription Services, Inc</publisher><subject>B-cell lymphoma ; Lymphoma</subject><ispartof>Hematological oncology, 2023-06, Vol.41 (S2), p.436-437</ispartof><rights>2023 The Authors. Hematological Oncology published by John Wiley & Sons, Ltd.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fhon.3164_321$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fhon.3164_321$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,45550,45551</link.rule.ids></links><search><creatorcontrib>Caimi, P. F.</creatorcontrib><creatorcontrib>Cashen, A.</creatorcontrib><creatorcontrib>Gallogly, M.</creatorcontrib><creatorcontrib>Winter, A.</creatorcontrib><creatorcontrib>Boughan, K.</creatorcontrib><creatorcontrib>Ghobadi, A.</creatorcontrib><creatorcontrib>Jagadeesh, D.</creatorcontrib><creatorcontrib>Cooper, B.</creatorcontrib><creatorcontrib>Mehta‐Shah, N.</creatorcontrib><creatorcontrib>Dean, R.</creatorcontrib><creatorcontrib>Metheny, L.</creatorcontrib><creatorcontrib>Pohlman, B.</creatorcontrib><creatorcontrib>Bartlett, N. L.</creatorcontrib><creatorcontrib>Lima, M.</creatorcontrib><creatorcontrib>Kahl, B. S.</creatorcontrib><creatorcontrib>Hill, B. T.</creatorcontrib><title>Venetoclax combined with R‐ICE (VICER) for second line treatment of diffuse large B cell lymphoma refractory or relapsed after initial chemoimmunotherapy</title><title>Hematological oncology</title><subject>B-cell lymphoma</subject><subject>Lymphoma</subject><issn>0278-0232</issn><issn>1099-1069</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><recordid>eNp9kN9qFTEQxhdR8Nh65wMMeKPgtkn2by71UNtCaaFob0M2mbgp2c2a5NDuXR_Be9-uT2IOR2-dixmG-fF9zFcU7yg5oYSw09HPJxVta1Ex-qLYUMJ5SUnLXxYbwrq-JKxir4s3Md4Tkm-k3xS_73DG5JWTj6D8NNgZNTzYNMLt89Ovy-0ZfLjL_fYjGB8govKzBpcpSAFlmnBO4A1oa8wuIjgZfiB8AYXOgVunZfSThIAmSJV8WCGLBHRyidlGmoQB7GyTlQ7UiJO307SbfRoxyGU9Ll4Z6SK-_TuPiu9fz75tL8qrm_PL7eerUtGa1yVDJk2jzVDnwr6plWaaS4pa8063Xd8SiYpXTcdMzXRr2qaph4ESha0a6qo6Kt4fdJfgf-4wJnHvd2HOlqIiPecdZ3xPfTpQKvgY80tiCXaSYRWUiH38Iscv_sWf8eaAP1iH639ZcXFzvR_7vfoD1iKMPQ</recordid><startdate>202306</startdate><enddate>202306</enddate><creator>Caimi, P. F.</creator><creator>Cashen, A.</creator><creator>Gallogly, M.</creator><creator>Winter, A.</creator><creator>Boughan, K.</creator><creator>Ghobadi, A.</creator><creator>Jagadeesh, D.</creator><creator>Cooper, B.</creator><creator>Mehta‐Shah, N.</creator><creator>Dean, R.</creator><creator>Metheny, L.</creator><creator>Pohlman, B.</creator><creator>Bartlett, N. L.</creator><creator>Lima, M.</creator><creator>Kahl, B. S.</creator><creator>Hill, B. T.</creator><general>Wiley Subscription Services, Inc</general><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>7QO</scope><scope>7QP</scope><scope>7T7</scope><scope>7TK</scope><scope>7U9</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>K9.</scope><scope>M7N</scope><scope>P64</scope><scope>RC3</scope></search><sort><creationdate>202306</creationdate><title>Venetoclax combined with R‐ICE (VICER) for second line treatment of diffuse large B cell lymphoma refractory or relapsed after initial chemoimmunotherapy</title><author>Caimi, P. F. ; Cashen, A. ; Gallogly, M. ; Winter, A. ; Boughan, K. ; Ghobadi, A. ; Jagadeesh, D. ; Cooper, B. ; Mehta‐Shah, N. ; Dean, R. ; Metheny, L. ; Pohlman, B. ; Bartlett, N. L. ; Lima, M. ; Kahl, B. S. ; Hill, B. T.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1494-2e2af5dfb4444e854cd2d9a1edd97d67860aec93572f42d6f6554bb10ce6cb433</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>B-cell lymphoma</topic><topic>Lymphoma</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Caimi, P. F.</creatorcontrib><creatorcontrib>Cashen, A.</creatorcontrib><creatorcontrib>Gallogly, M.</creatorcontrib><creatorcontrib>Winter, A.</creatorcontrib><creatorcontrib>Boughan, K.</creatorcontrib><creatorcontrib>Ghobadi, A.</creatorcontrib><creatorcontrib>Jagadeesh, D.</creatorcontrib><creatorcontrib>Cooper, B.</creatorcontrib><creatorcontrib>Mehta‐Shah, N.</creatorcontrib><creatorcontrib>Dean, R.</creatorcontrib><creatorcontrib>Metheny, L.</creatorcontrib><creatorcontrib>Pohlman, B.</creatorcontrib><creatorcontrib>Bartlett, N. L.</creatorcontrib><creatorcontrib>Lima, M.</creatorcontrib><creatorcontrib>Kahl, B. S.</creatorcontrib><creatorcontrib>Hill, B. T.</creatorcontrib><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Neurosciences Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><jtitle>Hematological oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Caimi, P. F.</au><au>Cashen, A.</au><au>Gallogly, M.</au><au>Winter, A.</au><au>Boughan, K.</au><au>Ghobadi, A.</au><au>Jagadeesh, D.</au><au>Cooper, B.</au><au>Mehta‐Shah, N.</au><au>Dean, R.</au><au>Metheny, L.</au><au>Pohlman, B.</au><au>Bartlett, N. L.</au><au>Lima, M.</au><au>Kahl, B. S.</au><au>Hill, B. T.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Venetoclax combined with R‐ICE (VICER) for second line treatment of diffuse large B cell lymphoma refractory or relapsed after initial chemoimmunotherapy</atitle><jtitle>Hematological oncology</jtitle><date>2023-06</date><risdate>2023</risdate><volume>41</volume><issue>S2</issue><spage>436</spage><epage>437</epage><pages>436-437</pages><issn>0278-0232</issn><eissn>1099-1069</eissn><cop>Chichester</cop><pub>Wiley Subscription Services, Inc</pub><doi>10.1002/hon.3164_321</doi><tpages>2</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0278-0232 |
| ispartof | Hematological oncology, 2023-06, Vol.41 (S2), p.436-437 |
| issn | 0278-0232 1099-1069 |
| language | eng |
| recordid | cdi_proquest_journals_3089979293 |
| source | Wiley Online Library |
| subjects | B-cell lymphoma Lymphoma |
| title | Venetoclax combined with R‐ICE (VICER) for second line treatment of diffuse large B cell lymphoma refractory or relapsed after initial chemoimmunotherapy |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-07T19%3A32%3A15IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Venetoclax%20combined%20with%20R%E2%80%90ICE%20(VICER)%20for%20second%20line%20treatment%20of%20diffuse%20large%20B%20cell%20lymphoma%20refractory%20or%20relapsed%20after%20initial%20chemoimmunotherapy&rft.jtitle=Hematological%20oncology&rft.au=Caimi,%20P.%20F.&rft.date=2023-06&rft.volume=41&rft.issue=S2&rft.spage=436&rft.epage=437&rft.pages=436-437&rft.issn=0278-0232&rft.eissn=1099-1069&rft_id=info:doi/10.1002/hon.3164_321&rft_dat=%3Cproquest_cross%3E3089979293%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3089979293&rft_id=info:pmid/&rfr_iscdi=true |